CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

Idiopathic pulmonary arterial hypertension (IPAH) is a rare cardiovascular disease of unknown etiology, characterized by pulmonary vascular resistance (PVR) and pulmonary artery pressure (PAP) increase due to pronounced remodeling of small pulmonary arteries and arterioles, with progressive deterior...

ver descrição completa

Detalhes bibliográficos

Principais autores:	T. V. Martynyuk, M. A. Saidova, N. M. Danilov, V. K. Lazutkina, I. Ye. Chazova
Formato:	Artigo
Idioma:	Russo
Publicado em:	InterMedservice 2015-12-01
coleção:	Евразийский Кардиологический Журнал
Assuntos:	idiopathic pulmonary hypertension endothelin-1 endothelin receptor antagonists ambrisentan идиопатическая лёгочная гипертензия эндотелин-1 антагонисты рецепторов эндотелина амбризентан
Acesso em linha:	https://www.heartj.asia/jour/article/view/5655
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!